Alivus Life Sciences Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Jun'24

Mar'24

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Sep 2025 is -2.30% vs -7.34% in Jun 2025

Standalone Net Profit

QoQ Growth in quarter ended Sep 2025 is 6.99% vs -14.33% in Jun 2025

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2025 is 3.98% vs -13.17% in Jun 2025

Interest

QoQ Growth in quarter ended Sep 2025 is 5.60% vs -0.79% in Jun 2025

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

Compare Quarterly Results Of Alivus Life With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

587.98

877.41

-289.43

-32.99%

Other Operating Income

0.00

14.20

-14.20

-100.00%

Total Operating income

587.98

891.61

-303.63

-34.05%

Raw Material Cost

288.96

351.11

-62.15

-17.70%

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

-40.04

21.73

-61.77

-284.26%

Employee Cost

66.40

104.35

-37.95

-36.37%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

93.49

203.01

-109.52

-53.95%

Total Expenditure (Excl Depreciation)

408.81

680.20

-271.39

-39.90%

Operating Profit (PBDIT) excl Other Income

179.17

211.41

-32.24

-15.25%

Other Income

14.72

7.89

6.83

86.57%

Operating Profit (PBDIT)

193.89

219.30

-25.41

-11.59%

Interest

1.32

16.65

-15.33

-92.07%

Exceptional Items

0.00

Gross Profit (PBDT)

192.57

202.65

-10.08

-4.97%

Depreciation

18.44

40.74

-22.30

-54.74%

Profit Before Tax

174.14

161.91

12.23

7.55%

Tax

44.11

41.29

2.82

6.83%

Provisions and contingencies

0.00

Profit After Tax

130.03

120.61

9.42

7.81%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

130.03

120.61

9.42

7.81%

Equity Capital

25.43

24.26

1.17

4.82%

Face Value

2.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

10.23

4.97

5.26

105.84%

Diluted Earnings per share

10.60

4.97

5.63

113.28%

Operating Profit Margin (Excl OI)

30.47%

24.09%

0.00

6.38%

Gross Profit Margin

32.75%

23.10%

0.00

9.65%

PAT Margin

22.11%

13.75%

0.00

8.36%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 587.98 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is -2.30% vs -7.34% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 16.00% vs -14.86% in Sep 2024

Quarterly - Standalone Net Profit

Standalone Net Profit 130.03 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 6.99% vs -14.33% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 36.41% vs -19.72% in Sep 2024

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 179.17 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 3.98% vs -13.17% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 33.35% vs -19.58% in Sep 2024

Quarterly - Interest

Interest 1.32 Cr

in Sep 2025

Figures in Cr

QoQ Growth in quarter ended Sep 2025 is 5.60% vs -0.79% in Jun 2025

YoY Growth in quarter ended Sep 2025 is 288.24% vs -15.00% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 30.47%

in Sep 2025

Figures in %

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024